Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02983786 · ClinicalTrials.gov registry record
Detection of Cerebral Ischemia With a Noninvasive Neurometabolic Optical Monitor
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 29
- Enrollment target
NCT02983786: Completed study, sponsored by University of Pennsylvania.
NCT02983786 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02983786 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
The goals of the project are to evaluate a noninvasive monitor of brain metabolism and blood flow in critically ill humans. If validated, such a reliable noninvasive brain blood flow and metabolism monitor, by allowing physiologic and pharmacologic decisions based on real-time brain physiology, potentially will become an important tool for clinicians in their efforts to prevent additional brain tissue death in patients admitted with stroke, brain hemorrhage and traumatic brain injury.
Interventions
- DRUG Indocyanine Green
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2015-12 |
| Est. Completion | 2022-05-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02983786
The ClinicalTrials.gov registry entry for NCT02983786 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Indocyanine Green is the first listed.
NCT02983786 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02983786 about?
NCT02983786 is a clinical study titled "Detection of Cerebral Ischemia With a Noninvasive Neurometabolic Optical Monitor". The goals of the project are to evaluate a noninvasive monitor of brain metabolism and blood flow in critically ill humans. If validated, such a reliable noninvasive brain blood flow and metabolism monitor, by allowing physiologic and pharmacologic decisions based on real-time brain physiology, pote...
What is the current status of trial NCT02983786?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2015-12. Estimated completion is 2022-05-25.
What interventions are being tested in trial NCT02983786?
The interventions under investigation include: Indocyanine Green (DRUG).
Who is sponsoring clinical trial NCT02983786?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.